Monopar Therapeutics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $2.8M | $2.8M |
| FY2016 | — | $2.8M | $2.1M |
| FY2017 | — | $9.6M | $9.0M |
| FY2018 | — | $6.9M | $6.9M |
| FY2019 | — | $12.6M | $13.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $2.8M | $2.8M |
| FY2016 | — | $2.8M | $2.1M |
| FY2017 | — | $9.6M | $9.0M |
| FY2018 | — | $6.9M | $6.9M |
| FY2019 | — | $12.6M | $13.2M |